These changes not only improve gut health but also enhance resistance to neuroinflammation by regulating the host immune system (69)
Although investor concerns about the MedTech Sector have been based on expected declines in obesity rates with the surging adoption of GLP-1s, IQVIA MedTechs analysis of the data tells a different story, overall, that - to date - obesity diagnoses remain stable during the rise of GLP-1 uptake as depicted below: As a result, the resilience of obesity diagnosis occurring despite the rising uptake of GLP-1s should serve as a positive general signal for MedTech industry players to counter investor concerns about the potential of reduced demand, or that the demand may be net-neutral, rather than a sudden decline
Patients should not assume that TB-500 is a proven treatment for tendon injuries, muscle tears, joint pain, or athletic recovery
A mendelian randomisation analysis reveals no relationship between periodontitis and coronary atherosclerosis
Practical Tips to Maximize Savings Plan ahead: Ordering a larger number of vials in one purchase is more cost-effective than making several smaller orders
